SEC Filing Summary

This filing details a transaction by Corazon D. Sanders, a director at Legend Biotech Corp. On September 24, 2026, Sanders acquired 20,986 ordinary shares with a transaction price of $0.00. Following this transaction, Sanders owns 80,101 ordinary shares. This transaction is related to restricted share units (RSUs), with 1/3 vesting on December 20, 2027, and the remainder vesting quarterly starting March 20, 2028, contingent upon continued service. The Ordinary Shares may be represented by American Depositary Shares (ADSs), with each ADS representing two ordinary shares.